Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Cohance Lifesciences Share Price
Cohance Lifesciences Ltd.
₹428.75
10.20(2.44%)
Invest in COHANCE with up to 2.50x margin.
Trade with MTF25th May 2026 | 10:57 AM
NSE : COHANCE
Open Free Demat Account
Cohance Lifesciences Performance
Price Movement
₹428.75
₹422.00
₹440.00
↘ Today's Low↗ Today's High
1 Year Performance
₹428.75
₹266.70
₹1121.15
↘ 52 Week Low↗ 52 Week High
Markets Today
High₹440.00
Low₹422.00
Open at₹422.00
Prev Close₹418.55
Volumes7.87 L
Avg Price₹432.23
Lower Circuit₹334.85
Upper Circuit₹502.25
Historical Performance
3M High₹514.90
3M Low₹266.70
1 Yr High₹1,121.15
1 Yr Low₹266.70
3 Yr High₹1,360.00
3 Yr Low₹266.70
5 Yr High₹1,360.00
5 Yr Low₹266.70
Cohance Lifesciences Fundamentals
Market Cap
High in industry
16,073.60 Cr.
PE Ratio (TTM)
High in industry
89.70
Dividend Yield
0
Net Profit TTM
33% decr over last year
179.23
Net Profit Growth
33% decr over last year
179.23
PEG Ratio
Negative PEG TTM
-2.70
ROE
71% decr over last year
4.58
Operating Revenue TTM
2,268.55
Operating Revenue Growth
89.4% incr over last year
Book Value
Above industry Median
4.20
MFI
MFI is mid-range
56.97
RSI
RSI is mid-range
49.60
EPS (TTM)
4.69
Debt to Equity
0.04
Face Value
1
Operating Profit Margin Qtr.
18.54
Operating Profit Qtr.
98.68
Net Profit Qtr.
19.55
Operating Revenue Qtr.
619.12
PB Ratio
4.20
Cohance Lifesciences Financials
*All values are in Rs. Cr
Loading chart...
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 567.55 | 481.58 | 497.79 | 483.58 | 330.17 |
| Operating Expense | 450.98 | 378.80 | 366.93 | 379.38 | 262.99 |
| Operating Profit | 116.57 | 102.78 | 130.86 | 104.20 | 67.18 |
| Depreciation | 37.66 | 33.36 | 31.20 | 31.36 | 15.19 |
| Interest | 5.17 | 5.25 | 5.24 | 6.80 | 2.30 |
| Tax | 21.88 | 18.14 | 26.43 | 18.47 | 11.98 |
| Net Profit | 34.56 | 47.29 | 94.29 | 52.57 | 44.34 |
Cohance Lifesciences Technicals
Cohance Lifesciences Ltd. EMA & SMA
₹428.75
0.40 (0.09%)
↗ Bullish Moving Average
4
↘ Bearish Moving Average
12
Day EMA5 ₹431.9
Day EMA10 ₹440.7
Day EMA12 ₹440.8
Day EMA20 ₹432.2
Day EMA26 ₹423
Day EMA50 ₹402.4
Day EMA100 ₹435.8
Day EMA200 ₹561.6
Cohance Lifesciences Support and Resistance
Resistance
First Resistance₹427.68
Second Resistance₹435.22
Third Resistance₹441.48
Support
First Support₹413.88
Second Support₹407.62
Third Support₹400.08
Technical Indicators
Day RSI49.60
Day MFI56.97
Day ADX39.84
Day Commodity Channel Index-46.00
William-74.46
Day MACD17.77
Day MACD Signal Line27.98
Day ATR30.64
Day ROC125-31.74
Day ROC2113.80
Cohance Lifesciences Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 50.1 | 50.1 | 66.4 | 57.5 | 57.5 | 57.5 |
| FII | 10.8 | 11 | 7.2 | 6.5 | 6 | 5.6 |
| DII | 16.7 | 16.7 | 11.4 | 20.8 | 21.6 | 21.8 |
| Public | 22.4 | 22.2 | 15 | 15.2 | 14.9 | 15.1 |
Cohance Lifesciences Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 13.96 L | 1.08 Cr | 12.96% |
| Week | 15.91 L | 53.22 L | 29.89% |
| 1 Month | 15.96 L | 70.36 L | 22.68% |
| 6 Month | 7.02 L | 26.52 L | 26.49% |
Cohance Lifesciences SWOT Analysis
Strengths8
Weakness14
Opportunity2
Threats0
Benjamin Graham Value Screen
Relative Outperformance versus Industry over 1 Month
Expensive Performers (DVM)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Companies with Zero Promoter Pledge
Stocks Outperforming their Industry Price Change in the Quarter
Cohance Lifesciences Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 09 Sep, 2022 | 1 | INTERIM | 12 Sep, 2022 | Equity Share |
| 09 Sep, 2022 | 5 | SPECIAL | 12 Sep, 2022 | Equity Share |
| 13 May, 2022 | 1 | INTERIM | 17 May, 2022 | Equity Share |
| 13 May, 2022 | 1 | SPECIAL | 17 May, 2022 | Equity Share |
| 15 Feb, 2022 | 1 | INTERIM | 16 Feb, 2022 | Equity Share |
| 15 Feb, 2022 | 2 | SPECIAL | 16 Feb, 2022 | Equity Share |
| 13 Aug, 2021 | 1 | FINAL | 17 Aug, 2021 | Equity Share |
| 17 Feb, 2021 | 1 | INTERIM | 18 Feb, 2021 | Equity Share |
Cohance Lifesciences Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,699.90 | ₹724.95 | ₹953.50 | ₹1,145.70 | ₹4,689.70 | ₹519.30 |
| % Change | 0.91% | 7.66% | 0.39% | 3.13% | -0.96% | -0.14% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | - | ₹1,598.19 | ₹649.50 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | - | ₹206.20 | ₹115.38 | ₹257.90 | ₹255.19 |
| PE TTM | 57.20 | - | 78.90 | 43.30 | 43.40 | 31.80 |
| 1 Year Return | 63.07 | 9.63 | 103.31 | 111.14 | -2.21 | -6.77 |
| ROCE | 31.54 | 34.78 | 34.76 | 15.60 | - | 11.40 |
Similar Stocks
BLUEJET
Blue Jet Healthcare Ltd
₹ 445.35
+0.97%
CONCORDBIO
Concord Biotech Ltd.
₹ 1156.70
+0.29%
AARTIPHARM
Aarti Pharmalabs Ltd.
₹ 727.80
+2.06%
SUPRIYA
Supriya Lifescience Ltd.
₹ 783.45
+1.21%
ALIVUS
Alivus Life Sciences Ltd.
₹ 1041.50
+0.24%
ERIS
Eris Lifesciences Ltd.
₹ 1345.10
+0.10%
SYNGENE
Syngene International Ltd.
₹ 465.80
+0.86%
APLLTD
Alembic Pharmaceuticals Ltd.
₹ 757.50
+0.24%
SPARC
Sun Pharma Advanced Research Company Ltd.
₹ 226.41
+7.93%
STAR
Strides Pharma Science Ltd.
₹ 1176.60
+2.03%
GRANULES
Granules India Ltd.
₹ 760.30
+1.11%
FDC
FDC Ltd.
₹ 369.70
-0.95%
SHILPAMED
Shilpa Medicare Ltd.
₹ 510.85
+4.20%
JUBLPHARMA
Jubilant Pharmova Ltd.
₹ 970.00
-3.61%
CAPLIPOINT
Caplin Point Laboratories Ltd.
₹ 2067.00
+1.92%
MARKSANS
Marksans Pharma Ltd.
₹ 218.90
+3.32%
SANOFI
Sanofi India Ltd.
₹ 3159.40
-0.12%
PGHL
Procter & Gamble Health Ltd.
₹ 5601.00
+0.86%
JSLL
Jeena Sikho Lifecare Ltd.
₹ 628.00
-3.35%
FAQ's on COHANCE
What is the current share price of Cohance Lifesciences Ltd.?
As of 6 June 2025 at 10:01 AM, the share price for Cohance Lifesciences Ltd. is ₹ 428.75 on the NSE and ₹ 428.7 on the BSE. (Note: Prices are dynamic and update frequently during market hours).
What is the Market Capitalization of Cohance Lifesciences Ltd.?
Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Cohance Lifesciences Ltd. is approximately ₹ 16073.6 Cr.
What are the PE and PB ratios for Cohance Lifesciences Ltd.?
Based on recent data, the Price-to-Earnings (PE) ratio for Cohance Lifesciences Ltd. is 89.7, and the Price-to-Book (PB) ratio is 4.2.
What is the 52-Week High and Low for Cohance Lifesciences Ltd.?
Over the past 52 weeks, the highest price reached by Cohance Lifesciences Ltd. shares was ₹ 1121.15, and the lowest price was ₹ 266.7.
Who are the major shareholders of Cohance Lifesciences Ltd.?
Significant shareholdings in Cohance Lifesciences Ltd. typically include entities such as:
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
- Promoter
- Mutual Funds
- Public
- FII
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Cohance Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?
In the Pharmaceuticals & Biotechnology sector, Cohance Lifesciences Ltd. is often compared with other major players such as
Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.
What is the latest dividend information for Cohance Lifesciences Ltd.?
Cohance Lifesciences Ltd. last declared a INTERIM dividend of ₹ 1 per share for the financial period ending 2022. The record date was set as 2022-09-09, and the payment was/is scheduled around 2022-09-09. For the most current dividend announcements, refer to official company filings.
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy